Literature DB >> 22282406

Contrast-enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism.

Mao-Yuan M Su1, Vin-Cent Wu, Hsi-Yu Yu, Yen-Hung Lin, Chin-Chi Kuo, Kao-Lang Liu, Shuo-Meng Wang, Shih-Chieh Chueh, Lian-Yu Lin, Kwan-Dun Wu, Wen-Yih I Tseng.   

Abstract

PURPOSE: To assess the degree of myocardial fibrosis in patients with primary aldosteronism (PA).
MATERIALS AND METHODS: Twenty-five patients with PA and 12 age-matched healthy volunteers underwent cine and late gadolinium enhancement (LGE) magnetic resonance imaging (MRI) on a 1.5 T MR system. From volume-time curves of cine MRI, the time for deceleration (Tdec) was determined to assess the left ventricle (LV) chamber stiffness. Based on phase-sensitive reconstructed LGE images, a fibrosis index called enhancement value (EV) was computed as the signal intensity change in the myocardium over blood before and after contrast. Both Tdec and EV were compared between patients and controls. The association between Tdec and EV was investigated.
RESULTS: Patients showed a significantly higher EV (0.43 ± 0.05 vs. 0.36 ± 0.07; P = 0.002) and a significantly shorter Tdec (11.5 ± 3.5 %RR vs. 15.3 ± 2.4 %RR; P = 0.004) than controls. Significant correlations between EV and Tdec were observed in patients (r = -0.46, P = 0.018), in controls (r = -0.68, P = 0.015) and in all subjects (r = -0.63, P < 0.001).
CONCLUSION: The fibrosis index is increased in patients with PA and the increase imposes an adverse effect on LV diastolic function.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282406     DOI: 10.1002/jmri.23592

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.

Authors:  Pascale Beliveau; Farida Cheriet; Stasia A Anderson; Joni L Taylor; Andrew E Arai; Li-Yueh Hsu
Journal:  Comput Biol Med       Date:  2015-08-08       Impact factor: 4.589

Review 2.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 3.  Left ventricular remodeling and dysfunction in primary aldosteronism.

Authors:  Cheng-Hsuan Tsai; Chien-Ting Pan; Yi-Yao Chang; Zheng-Wei Chen; Vin-Cent Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Hum Hypertens       Date:  2020-10-16       Impact factor: 3.012

Review 4.  Treatment of Primary Aldosteronism and Organ Protection.

Authors:  Cristiana Catena; GianLuca Colussi; Leonardo A Sechi
Journal:  Int J Endocrinol       Date:  2015-05-17       Impact factor: 3.257

5.  Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism.

Authors:  Marianne Aa Grytaas; Kjersti Sellevåg; Hrafnkell B Thordarson; Eystein S Husebye; Kristian Løvås; Terje H Larsen
Journal:  Endocr Connect       Date:  2018-02-12       Impact factor: 3.335

Review 6.  Strain Imaging for the Early Detection of Cardiac Remodeling and Dysfunction in Primary Aldosteronism.

Authors:  Yilin Chen; Tingyan Xu; Jianzhong Xu; Limin Zhu; Dian Wang; Yan Li; Jiguang Wang
Journal:  Diagnostics (Basel)       Date:  2022-02-20

7.  CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients.

Authors:  Fangli Zhou; Tao Wu; Wei Wang; Wei Cheng; Shuang Wan; Haoming Tian; Tao Chen; Jiayu Sun; Yan Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.